Sign in Subscribe

nras

A collection of 4 issues

KRAS, NRAS, and BRAF mutation patterns in Chile

Skip to content The CRC Digest KRAS, NRAS, and BRAF mutation patterns in Chile Real-world data from 999 Chilean patients characterized the frequency and sex-specific distribution of KRAS, NRAS, and BRAF mutations. (Journal of Gastrointestinal Oncology) This content is informational only and does not constitute medical advice. Always consult your

CRC Research Update — July 10, 2026

Today's colorectal cancer research highlights

Sotorasib Plus Panitumumab Produces Response in Rare NRAS G12C-Mutated MSI-H Rectal Cancer

Skip to content The CRC Digest Sotorasib Plus Panitumumab Produces Response in Rare NRAS G12C-Mutated MSI-H Rectal Cancer A case report describes an objective tumor response to the KRAS G12C inhibitor sotorasib combined with EGFR blockade in a patient with advanced NRAS G12C-mutated, mismatch repair-deficient rectal adenocarcinoma refractory to immunotherapy.

CRC Research Update — June 25, 2026

Today's colorectal cancer research highlights